Snowball logo
logo
KMPH_logo

KemPharm Inc

-- $$0.00Β  (0%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20182019202020212022TTM
Revenue
Total revenue
-12.8413.2928.6510.469.372
COGS
-2.9451.3052.0590.3430.46
Gross Profit
-9.89411.9826.5910.128.912
Operating Expenses & Income
Operating Income
(55.9)(20.34)(4.781)7.729(24.84)(16.61)
Total Operating Expenses
54.2730.2316.7618.8634.9627.16
R&D Expenses
41.7619.418.84310.1619.6130.34
Selling General & Admin Expenses
12.5110.827.9218.70115.3419.44
Earnings from Continuing Operations
Interest Expense
(7.087)(6.514)(7.09)(0.376)(0.335)(0.36)
Interest Income
0.420.3090.0890.2480.760.093
Income Tax Expense
(0.126)(0.022)(0.034)0.034(0.786)(12.65)
Net Income
Net Income
(56.47)(24.52)(12.76)(8.555)(41.54)(39.68)
Supplemental
EBIT
(49.51)(20.34)(4.781)7.729(24.84)(16.61)
EBITDA
(49.18)(20.03)(4.692)7.977(24.08)(16.69)
In millions of USD, except % and values per 1 share